Nine Blue Chip Companies Reject Tokenized Stocks

Corporate consent is emerging as a real constraint on tokenized equities, not a purely technical or regulatory one. The refusal by established names shifts the burden onto platforms and issuers, who must now build products around assets whose underlying companies are unwilling participants — a structural gap that could narrow the addressable market. Whether this hardens into a broader corporate stance or remains a scattered set of holdouts is the open question, and it will shape how tokenized equity products are structured and marketed.